IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q2 2016 Holdings

Filed 2016-08-15 | 15 holdings | $78.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$75.0M310,00095.7%
Abbvie Inc.(ABBV)COM00287Y109$3.1M50,0004.0%
Ariad Pharmaceuticals IncCOM04033A100$95.0K12,850,0000.1%
Medicines CoCOM584688105$58.9K1,752,0000.1%
Intra Cellular Therapies Inc(ITCIEUR)COM46116X101$26.2K675,0000.0%
Pacira Pharmaceuticals Inc(PCRX)COM695127100$22.0K653,0000.0%
Raptor Pharmaceutical CorpCOM75382F106$15.4K2,875,0000.0%
Array Biopharma Inc(ARRYEUR)COM04269X105$15.3K4,300,0000.0%
Quest Diagnostics Inc(DGX)COM74834L100$12.9K159,0000.0%
Perrigo Co PLC(PRGO)SHSG97822103$9.1K100,0000.0%
Apricus Biosciences IncCOM03832V109$5.8K14,479,0520.0%
Advaxis IncCOM NEW007624208$4.9K600,0000.0%
Aegerion Pharmaceuticals IncCOM00767E102$3.9K2,649,0000.0%
Vivus IncCOM928551100$2.9K2,573,9430.0%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$1.9K2,000,0000.0%